ABL1 | C-abl oncogene 1, non-receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | ![](/images/27280/ihc_cell_selected_60x60.jpg) | ![](/images/28409/61493_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
ABL2 | C-abl oncogene 2, non-receptor tyrosine kinase | Cancer-related genes Enzymes RAS pathway related proteins
| ![](/images/1866/ihc_selected_60x60.jpg) | | ![](/images/1866/ihc_cell_selected_60x60.jpg) | ![](/images/17106/38942_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
AFF3 | AF4/FMR2 family, member 3 | Cancer-related genes
| ![](/images/44512/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/44512/99012_B_9_7_rna_selected_60x60.jpg) | Mixed |
AFF4 | AF4/FMR2 family, member 4 | Cancer-related genes Disease related genes
| ![](/images/23690/ihc_selected_60x60.jpg) | | ![](/images/23690/ihc_cell_selected_60x60.jpg) | ![](/images/23690/51734_A_3_3_rna_selected_60x60.jpg) | Expressed in all |
AKAP9 | A kinase (PRKA) anchor protein 9 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted membrane proteins
| | | ![](/images/8548/ihc_cell_selected_60x60.jpg) | ![](/images/8548/23971_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | ![](/images/2891/7679_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
ARID1A | AT rich interactive domain 1A (SWI-like) | Cancer-related genes Disease related genes Transcription factors
| | | ![](/images/16334/ihc_cell_selected_60x60.jpg) | ![](/images/5456/19570_B_7_3_rna_selected_60x60.jpg) | Expressed in all |
ARID2 | AT rich interactive domain 2 (ARID, RFX-like) | Cancer-related genes Transcription factors
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Expressed in all |
ARNT | Aryl hydrocarbon receptor nuclear translocator | Cancer-related genes Transcription factors
| | | | ![](/images/4318/11330_B_1_7_rna_selected_60x60.jpg) | Expressed in all |
ASPSCR1 | Alveolar soft part sarcoma chromosome region, candidate 1 | Cancer-related genes Disease related genes
| ![](/images/26749/ihc_selected_60x60.jpg) | | ![](/images/26749/ihc_cell_selected_60x60.jpg) | ![](/images/26749/58071_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
ATF1 | Activating transcription factor 1 | Cancer-related genes Disease related genes Transcription factors
| | | ![](/images_static/rna_center.gif) | ![](/images/16222/36028_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
ATIC | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/13462/28449_B_2_4_rna_selected_60x60.jpg) | Expressed in all |
ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/1583/5182_B_7_5_rna_selected_60x60.jpg) | Group enriched |
ATRX | Alpha thalassemia/mental retardation syndrome X-linked | Cancer-related genes Disease related genes Enzymes Potential drug targets Transcription factors
| | | ![](/images/1906/ihc_cell_selected_60x60.jpg) | ![](/images/1906/7642_B_3_2_rna_selected_60x60.jpg) | Expressed in all |
AXIN1 | Axin 1 | Cancer-related genes Disease related genes Plasma proteins
| | | ![](/images/12987/ihc_cell_selected_60x60.jpg) | ![](/images/12987/28845_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
BAP1 | BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) | Cancer-related genes Disease related genes Enzymes Potential drug targets
| ![](/images/4322/ihc_selected_60x60.jpg) | | ![](/images/28814/ihc_cell_selected_60x60.jpg) | ![](/images/4322/11863_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
BCL11A | B-cell CLL/lymphoma 11A (zinc finger protein) | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| ![](/images/29003/ihc_selected_60x60.jpg) | | | ![](/images/29003/123910_B_8_8_rna_selected_60x60.jpg) | Mixed |
BCL3 | B-cell CLL/lymphoma 3 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| ![](/images/2051/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/2051/5530_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
BIRC3 | Baculoviral IAP repeat containing 3 | Cancer-related genes Disease related genes Plasma proteins
| ![](/images/2317/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/2317/8878_B_8_7_rna_selected_60x60.jpg) | Mixed |
BRCA1 | Breast cancer 1, early onset | Cancer-related genes Disease related genes Plasma proteins
| | | ![](/images/1946/ihc_cell_selected_60x60.jpg) | ![](/images/34966/89240_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
BRCA2 | Breast cancer 2, early onset | Cancer-related genes Disease related genes
| ![](/images/26815/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/26815/59972_B_9_1_rna_selected_60x60.jpg) | Mixed |
BRD4 | Bromodomain containing 4 | Cancer-related genes Disease related genes
| | | ![](/images_static/rna_center.gif) | ![](/images/68178/152032_A_8_7_rna_selected_60x60.jpg) | Expressed in all |
CAMTA1 | Calmodulin binding transcription activator 1 | Cancer-related genes Disease related genes
| ![](/images/36343/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/36343/77668_B_6_7_rna_selected_60x60.jpg) | Expressed in all |
CARS | Cysteinyl-tRNA synthetase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | ![](/images/2384/8118_A_1_7_rna_selected_60x60.jpg) | Expressed in all |
CASC5 | Cancer susceptibility candidate 5 | Cancer-related genes Disease related genes Plasma proteins
| | | | ![](/images/26624/56299_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
CASP8 | Caspase 8, apoptosis-related cysteine peptidase | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets
| ![](/images/1302/ihc_selected_60x60.jpg) | | ![](/images/1302/ihc_cell_selected_60x60.jpg) | ![](/images/1302/30721_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
CBL | Cbl proto-oncogene, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes
| | | ![](/images/27956/ihc_cell_selected_60x60.jpg) | ![](/images/4350/11497_B_2_7_rna_selected_60x60.jpg) | Mixed |
CBLB | Cbl proto-oncogene B, E3 ubiquitin protein ligase | Cancer-related genes
| ![](/images/18327/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/19880/45308_B_7_2_rna_selected_60x60.jpg) | Expressed in all |
CCDC6 | Coiled-coil domain containing 6 | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | ![](/images/19049/46013_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
CCND1 | Cyclin D1 | Cancer-related genes Disease related genes FDA approved drug targets
| ![](/images/24/ihc_selected_60x60.jpg) | | | ![](/images/24/71_B_8_6_rna_selected_60x60.jpg) | Mixed |
CCND2 | Cyclin D2 | Cancer-related genes
| ![](/images/49138/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/49138/110514_A_3_5_rna_selected_60x60.jpg) | Mixed |
CCNE1 | Cyclin E1 | Cancer-related genes
| ![](/images/308/ihc_selected_60x60.jpg) | | ![](/images/16682/ihc_cell_selected_60x60.jpg) | ![](/images/18169/43893_A_2_4_rna_selected_60x60.jpg) | Tissue enhanced |
CD79B | CD79b molecule, immunoglobulin-associated beta | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/9178/26322_A_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
CDC73 | Cell division cycle 73 | Cancer-related genes Disease related genes
| | | ![](/images_static/rna_center.gif) | ![](/images/16359/36099_B_9_4_rna_selected_60x60.jpg) | Expressed in all |
CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | ![](/images/4812/15140_B_9_7_rna_selected_60x60.jpg) | Mixed |
CDK12 | Cyclin-dependent kinase 12 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | ![](/images/8038/ihc_cell_selected_60x60.jpg) | ![](/images/8038/21427_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
CDK6 | Cyclin-dependent kinase 6 | Cancer-related genes Enzymes Plasma proteins
| | | | ![](/images/2637/10824_B_7_3_rna_selected_60x60.jpg) | Mixed |
CDKN2A | Cyclin-dependent kinase inhibitor 2A | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| ![](/images/18232/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/18232/41222_B_8_6_rna_selected_60x60.jpg) | Mixed |
CDX2 | Caudal type homeobox 2 | Cancer-related genes Transcription factors
| | | | ![](/images/2221/5839_B_9_3_rna_selected_60x60.jpg) | Group enriched |
CIC | Capicua transcriptional repressor | Cancer-related genes Transcription factors
| | | ![](/images/44341/ihc_cell_selected_60x60.jpg) | ![](/images/26388/54064_A_3_3_rna_selected_60x60.jpg) | Expressed in all |
CLP1 | Cleavage and polyadenylation factor I subunit 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | ![](/images/57770/130501_B_7_2_rna_selected_60x60.jpg) | Expressed in all |
CLTC | Clathrin, heavy chain (Hc) | Cancer-related genes Plasma proteins
| | | ![](/images/10389/ihc_cell_selected_60x60.jpg) | ![](/images/10389/32646_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
CNTRL | Centriolin | Cancer-related genes Disease related genes Plasma proteins
| ![](/images/20468/ihc_selected_60x60.jpg) | | ![](/images/20480/ihc_cell_selected_60x60.jpg) | ![](/images/20468/132075_B_7_4_rna_selected_60x60.jpg) | Mixed |
COX6C | Cytochrome c oxidase subunit VIc | Cancer-related genes Mitochondrial proteins Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/16244/36048_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
CREB1 | CAMP responsive element binding protein 1 | Cancer-related genes Disease related genes Transcription factors
| | | ![](/images/3803/ihc_cell_selected_60x60.jpg) | ![](/images/19150/44741_B_2_5_rna_selected_60x60.jpg) | Expressed in all |
CREBBP | CREB binding protein | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | ![](/images/4212/ihc_cell_selected_60x60.jpg) | ![](/images/4212/12140_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
CRTC3 | CREB regulated transcription coactivator 3 | Cancer-related genes
| ![](/images/43735/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/43735/96145_B_9_7_rna_selected_60x60.jpg) | Expressed in all |
CTNNB1 | Catenin (cadherin-associated protein), beta 1, 88kDa | Cancer-related genes Disease related genes Plasma proteins
| | | | ![](/images/29160/62938_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
CYLD | Cylindromatosis (turban tumor syndrome) | Cancer-related genes Disease related genes Enzymes Potential drug targets
| ![](/images/11713/ihc_selected_60x60.jpg) | | ![](/images/11713/ihc_cell_selected_60x60.jpg) | ![](/images/11713/27309_B_3_4_rna_selected_60x60.jpg) | Expressed in all |
DAXX | Death-domain associated protein | Cancer-related genes
| | | | ![](/images/2224/5834_B_8_2_rna_selected_60x60.jpg) | Expressed in all |